يعرض 1 - 10 نتائج من 69 نتيجة بحث عن '"Proto-Oncogene Proteins c-akt/metabolism"', وقت الاستعلام: 1.17s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية

    المصدر: Oxidative Medicine and Cellular Longevity, 2019, 1036907 (2019)

    Relation: urn:issn:1942-0900; urn:issn:1942-0994

  3. 3

    المساهمون: Faculty of Pharmacy, Divisions of Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy, Drug Research Program, Regenerative pharmacology group, PREP in neurodegenerative disorders

    المصدر: Myöhänen, T T, Mertens, F, Norrbacka, S & Cui, H 2021, ' Deletion or inhibition of prolyl oligopeptidase blocks lithium-induced phosphorylation of GSK3b and Akt by activation of protein phosphatase 2A ', Basic and Clinical Pharmacology and Toxicology, vol. 129, no. 4, pp. 287-296 . https://doi.org/10.1111/bcpt.13632

  4. 4
  5. 5

    المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Translational Immunology Groningen (TRIGR)

    المصدر: International Journal of Molecular Sciences; Volume 23; Issue 14; Pages: 7853
    International Journal of Molecular Sciences, 23(14):7853. MDPI AG

    وصف الملف: application/pdf

  6. 6

    المساهمون: Bedrijfsbureau CD, RS: CARIM other

    المصدر: González-Blázquez, R, Alcalá, M, Fernández-Alfonso, M S, Steckelings, U M, Lorenzo, M P, Viana, M, Boisvert, W, Unger, T, Ortega, M G & Somoza, B 2021, ' C21 preserves endothelial function in the thoracic aorta from DIO mice : role for AT2, Mas and B2 receptors ', Clinical Science, vol. 135, no. 9, pp. 1145-1163 . https://doi.org/10.1042/CS20210049
    Clinical Science, 135(9), 1145-1163. Portland Press Ltd.

    مصطلحات موضوعية: Male, Receptor, Bradykinin B2, Drug Evaluation, Preclinical, Aorta, Thoracic, Vasodilation, Inbred C57BL, Proto-Oncogene Mas, Receptors, G-Protein-Coupled, Renin-Angiotensin System, Mice, Angiotensin, chemistry.chemical_compound, Bradykinin B2/metabolism, Signal Transduction/drug effects, Receptors, Proto-Oncogene Proteins c-akt/metabolism, Thoracic aorta, Thoracic/drug effects, Endothelial dysfunction, Receptor, Aorta, Vascular/drug effects, Imidazoles/pharmacology, Sulfonamides, Imidazoles, General Medicine, Receptor, Angiotensin, Type 2/agonists, Preclinical, Aorta, Thoracic/drug effects, Signal transduction, Signal Transduction, Type 2/agonists, Agonist, Endothelium, Vascular/drug effects, medicine.medical_specialty, Nitric Oxide Synthase Type III, Sulfonamides/pharmacology, medicine.drug_class, Bradykinin, Thiophenes/pharmacology, Thiophenes, Diet, High-Fat, Nitric Oxide, Cyclic AMP-Dependent Protein Kinases/metabolism, Receptor, Angiotensin, Type 2, Proto-Oncogene Proteins, medicine.artery, Internal medicine, Human Umbilical Vein Endothelial Cells, medicine, Animals, Humans, Endothelium, Obesity, Vascular Diseases, Receptor, Bradykinin B2/metabolism, Protein kinase B, G-Protein-Coupled/metabolism, Vascular Diseases/etiology, Nitric Oxide Synthase Type III/metabolism, Receptor Cross-Talk, Receptors, G-Protein-Coupled/metabolism, Proto-Oncogene Proteins/metabolism, medicine.disease, Cyclic AMP-Dependent Protein Kinases, Diet, Mice, Inbred C57BL, High-Fat, Endocrinology, chemistry, Renin-Angiotensin System/drug effects, Nitric Oxide/metabolism, Drug Evaluation, Endothelium, Vascular, Obesity/complications, Proto-Oncogene Proteins c-akt

  7. 7

    المصدر: Biochemical and biophysical research communications, vol. 513, no. 3, pp. 546-552

    وصف الملف: application/pdf

  8. 8

    المصدر: Cell reports, vol. 39, no. 13, pp. 111019

    وصف الملف: application/pdf

  9. 9

    المصدر: Biomedicine & Pharmacotherapy, Vol 144, Iss, Pp 112349-(2021)
    Chioua, T T-Y, Chau, Y-Y, Chen, J-B, Hsu, H-H, Huang, S-P & Lee, W-C 2021, ' Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway ', Biomedicine and Pharmacotherapy, vol. 144 . https://doi.org/10.1016/j.biopha.2021.112349

    وصف الملف: application/pdf

  10. 10

    المساهمون: Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Institut de biologie structurale (IBS - UMR 5075 ), Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Division of Public Health Sciences, Fred Hutchinson Cancer Research Center [Seattle] (FHCRC), Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Journal of Experimental Medicine
    Journal of Experimental Medicine, 2019, 216 (7), pp.jem.20182359. ⟨10.1084/jem.20182359⟩
    The Journal of experimental medicine, vol. 216, no. 7, pp. 1525-1541
    Journal of Experimental Medicine, Rockefeller University Press, 2019, 216 (7), pp.jem.20182359. ⟨10.1084/jem.20182359⟩
    The Journal of Experimental Medicine
    'Journal of Experimental Medicine ', vol: 216, pages: 1525-1541 (2019)

    وصف الملف: application/pdf